BIOTECHNOLOGY VALUE FUND II LP

CIK: 0001102444·Pooled Investment Fund·SAN FRANCISCO, CA

Reported Sold

N/A

Total Filings

16

Identified Offerings

0

Last Filed

Dec 23, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 16 unlinked amendments excluded.

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Company Info

View on SEC EDGAR

Track this company

Set up alerts to get notified when new Form D filings are submitted.

Track BIOTECHNOLOGY VALUE FUND II LP

Want to track companies like BIOTECHNOLOGY VALUE FUND II LP?

Set up saved searches and alerts for newly submitted Form D filings.

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 23, 2025	Amendment	N/A	$1,406,935,818	123
Dec 27, 2024	Amendment	Indefinite	$1,325,635,818	118
Dec 29, 2023	Amendment	Indefinite	$1,278,335,818	115
Dec 30, 2022	Amendment	Indefinite	$1,260,272,818	114
Jan 4, 2022	Amendment	Indefinite	$1,035,372,818	101
Jan 7, 2021	Amendment	Indefinite	$584,922,818	68
Jan 10, 2020	Amendment	Indefinite	$487,122,818	60
Jan 11, 2019	Amendment	Indefinite	$210,422,818	38
Dec 8, 2017	Amendment	Indefinite	$193,222,818	36
Sep 21, 2016	Amendment	Indefinite	$179,922,818	34
Nov 12, 2014	Amendment	Indefinite	$46,100,000	14
Nov 8, 2013	Amendment	Indefinite	$21,250,000	5
Nov 8, 2012	Amendment	Indefinite	$13,750,000	3
Nov 8, 2011	Amendment	Indefinite	$13,750,000	3
Oct 21, 2010	Amendment	Indefinite	$13,750,000	3
Oct 16, 2009	Amendment	Indefinite	$13,750,000	4

Offering filing timeline

Dec 23, 2025Form D/A — Amendment

Reported sold: $1,406,935,818 · Target: N/A

No verified predecessor available.

Rule 506(b)·123 investors·Section 3(c), Section 3(c)(7)

Dec 27, 2024Form D/A — Amendment

Reported sold: $1,325,635,818 · Target: Indefinite

Rule 506(b)·118 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Dec 29, 2023Form D/A — Amendment

Reported sold: $1,278,335,818 · Target: Indefinite

Rule 506(b)·115 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Dec 30, 2022Form D/A — Amendment

Reported sold: $1,260,272,818 · Target: Indefinite

Rule 506(b)·114 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Jan 4, 2022Form D/A — Amendment

Reported sold: $1,035,372,818 · Target: Indefinite

Rule 506(b)·101 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Jan 7, 2021Form D/A — Amendment

Reported sold: $584,922,818 · Target: Indefinite

Rule 506(b)·68 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Jan 10, 2020Form D/A — Amendment

Reported sold: $487,122,818 · Target: Indefinite

Rule 506(b)·60 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Jan 11, 2019Form D/A — Amendment

Reported sold: $210,422,818 · Target: Indefinite

Rule 506(b)·38 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Dec 8, 2017Form D/A — Amendment

Reported sold: $193,222,818 · Target: Indefinite

Rule 506(b)·36 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Sep 21, 2016Form D/A — Amendment

Reported sold: $179,922,818 · Target: Indefinite

Rule 506(b)·34 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 12, 2014Form D/A — Amendment

Reported sold: $46,100,000 · Target: Indefinite

Rule 506(b)·14 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 8, 2013Form D/A — Amendment

Reported sold: $21,250,000 · Target: Indefinite

Rule 506(b)·5 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Exemptions

Nov 8, 2012Form D/A — Amendment

Reported sold: $13,750,000 · Target: Indefinite

Rule 506·3 investors·Section 3(c), Section 3(c)(7)

Nov 8, 2011Form D/A — Amendment

Reported sold: $13,750,000 · Target: Indefinite

Rule 506·3 investors·Section 3(c), Section 3(c)(7)

Oct 21, 2010Form D/A — Amendment

Reported sold: $13,750,000 · Target: Indefinite

Rule 506·3 investors·Section 3(c), Section 3(c)(7)

Changed: Reported investors

Oct 16, 2009Form D/A — Amendment

Reported sold: $13,750,000 · Target: Indefinite

No verified predecessor available.

Rule 506·4 investors·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

123

Revenue Range

—

Reported commissions across identified offerings

N/A

Amendment Rate

100%

Latest reported sold across 0 identified offerings

N/A

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

16 unlinked amendments excluded.

Key People

BI

Executive Officer

Appears on 14 filings

MN

Mark N. Lampert

Executive Officer

Appears on 14 filings

BP

BVF Partners, L.P.

Executive Officer

Appears on 14 filings

MD

Matthew D. Perry

Related Person

Appears on 12 filings

JK

Executive Officer

Appears on 9 filings

JM

Executive Officer

Appears on 7 filings

BI

Executive Officer

Appears on 6 filings

BG

BVF GP Holdings LLC

Executive Officer

Appears on 6 filings